A Clinical & Scientific perspective on Lecanemab – UKDRI
Catch-up on the UKDRI Roundtable to discuss the promising Phase III trial data of lecanemab ollowing presentation of results from Eisai/Biogen at CTAD.
UK DRI
A path to therapies: key outstanding questions in dementia research
In July the UK Dementia Research Institute hosted a session at #FENS2020 Conference. Catch-up now to see Professor Bart De Strooper, Professor Karen Duff, Professor John Hardy and Professor Giovanna Mallucci.
Blood test set to transform detection of brain damage and poor prognosis after head injury
A new study has used a state-of-the-art blood test to track damage to the brain in people who have sustained traumatic brain injury (TBI). Measuring the protein biomarker in the blood will provide a simpler, more accurate way to predict clinical outcomes and may help to identify those at higher risk of developing dementia.
Call for Data Study Group challenges
The UK Dementia Research Institute, Deep Dementia Phenotyping Network and The Alan Turing Institute are seeking a range of research questions (challenges) across disciplines to better understand dementia-causing disorders.
Diversity & Dementia: how is research bridging the gap?
UK DRI webinar recording, featuring talks from leading researchers exploring diversity and dementia: how is research reducing health disparities
Making it Brain – What its like to be a dementia researcher
Catch-up on this fantastic webinar from the UK Dementia Research institute, a neuroscience research & career webinar for students
Making it Brain 2022 – Finding a Career in Neuroscience
Brilliant Neuroscience research & career webinars from the UK Dementia Research Institute aimed at for young people and students
Study reveals new genes associated with Alzheimer’s
UK DRI study identifies 75 genes associated with an increased risk of developing Alzheimer’s disease, including 42 new genes not previously implicated
Tools to translate: ECR perspective with Dr Wioleta Zelek
Interview with recently appointed UK DRI Emerging Leader and RAD Fellow, Dr Wioleta Zelek discussing her research journey & patenting research tools
UK Dementia Research Institute launches major new cellular model platform
Major cell model initiative for Alzheimer’s Disease Research, Led by Professor Julie Williams at Cardiff University – iPSC Platform to Model Alzheimer’s Disease Risk (IPMAR) – aims to become one of the largest cellular model resources available.